1-Phenyl-2-pyridin-3-yl-ethanone

ID: ALA57058

Cas Number: 1081-48-7

PubChem CID: 238335

Max Phase: Preclinical

Molecular Formula: C13H11NO

Molecular Weight: 197.24

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Cc1cccnc1)c1ccccc1

Standard InChI:  InChI=1S/C13H11NO/c15-13(12-6-2-1-3-7-12)9-11-5-4-8-14-10-11/h1-8,10H,9H2

Standard InChI Key:  DDEBMFBOWGAMAX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 15 16  0  0  0  0  0  0  0  0999 V2000
   -1.6750   -1.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0750   -1.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0375   -2.3417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6833   -0.5417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1958   -1.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5583   -1.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5583   -2.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4792   -2.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1958   -2.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7125   -1.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0458   -1.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4792   -1.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7125   -2.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2333   -1.4500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2333   -2.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  7  1  0
  4  1  2  0
  5  1  1  0
  6  2  1  0
  7  6  2  0
  8 12  1  0
  9  5  1  0
 10  5  2  0
 11  6  1  0
 12 11  2  0
 13  9  2  0
 14 10  1  0
 15 14  2  0
 13 15  1  0
  8  3  2  0
M  END

Alternative Forms

Associated Targets(non-human)

CYP11B1 Cytochrome P450 11B1 (71 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 197.24Molecular Weight (Monoisotopic): 197.0841AlogP: 2.51#Rotatable Bonds: 3
Polar Surface Area: 29.96Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: 13.16CX Basic pKa: 4.88CX LogP: 2.15CX LogD: 2.15
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.71Np Likeness Score: -0.81

References

1. Hays SJ, Tobes MC, Gildersleeve DL, Wieland DM, Beierwaltes WH..  (1984)  Structure-activity relationship study of the inhibition of adrenal cortical 11 beta-hydroxylase by new metyrapone analogues.,  27  (1): [PMID:6606707] [10.1021/jm00367a004]
2. Napoli JL, Counsell RE..  (1977)  New inhibitors of steroid 11beta-hydroxylase. Structure--activity relationship studies of metyrapone-like compounds.,  20  (6): [PMID:874952] [10.1021/jm00216a005]

Source